Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 3
1946 3
1947 2
1948 4
1949 3
1950 1
1951 1
1952 3
1953 4
1954 8
1955 4
1956 6
1957 1
1958 9
1959 6
1960 2
1961 9
1962 4
1963 9
1964 7
1965 3
1966 9
1967 9
1968 6
1969 7
1970 6
1971 8
1972 18
1973 21
1974 20
1975 21
1976 16
1977 26
1978 30
1979 29
1980 29
1981 32
1982 22
1983 28
1984 23
1985 22
1986 20
1987 13
1988 17
1989 20
1990 29
1991 16
1992 17
1993 12
1994 16
1995 13
1996 17
1997 15
1998 11
1999 16
2000 28
2001 14
2002 14
2003 13
2004 19
2005 14
2006 18
2007 14
2008 24
2009 25
2010 31
2011 31
2012 33
2013 39
2014 27
2015 31
2016 65
2017 80
2018 75
2019 62
2020 56
2021 71
2022 60
2023 54
2024 58
2025 48

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,594 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for beck, l
Search for Beck YL instead (1 results)
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology.
Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, Waikar SS, Chandraker A, Riella LV, Alexander MP, Troost JP, Chen J, Fermin D, Yee JL, Sampson MG, Beck LH Jr, Henderson JM, Greka A, Rennke HG, Weins A. Watts AJB, et al. Among authors: beck lh jr. J Am Soc Nephrol. 2022 Jan;33(1):238-252. doi: 10.1681/ASN.2021060794. Epub 2021 Nov 3. J Am Soc Nephrol. 2022. PMID: 34732507 Free PMC article.
Membranous Nephropathy: Core Curriculum 2021.
Alsharhan L, Beck LH Jr. Alsharhan L, et al. Among authors: beck lh jr. Am J Kidney Dis. 2021 Mar;77(3):440-453. doi: 10.1053/j.ajkd.2020.10.009. Epub 2021 Jan 21. Am J Kidney Dis. 2021. PMID: 33487481 Review.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. Among authors: beck la. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
Membranous Nephropathy: Updates on Management.
Bharati J, Waguespack DR, Beck LH Jr. Bharati J, et al. Among authors: beck lh jr. Adv Kidney Dis Health. 2024 Jul;31(4):299-308. doi: 10.1053/j.akdh.2024.04.004. Adv Kidney Dis Health. 2024. PMID: 39084755 Review.
Molecular Characterization of Membranous Nephropathy.
Sealfon R, Mariani L, Avila-Casado C, Nair V, Menon R, Funk J, Wong A, Lerner G, Hayashi N, Troyanskaya O, Kretzler M, Beck LH Jr. Sealfon R, et al. Among authors: beck lh jr. J Am Soc Nephrol. 2022 Jun;33(6):1208-1221. doi: 10.1681/ASN.2021060784. Epub 2022 Apr 27. J Am Soc Nephrol. 2022. PMID: 35477557 Free PMC article.
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
Beck LA, Thaçi D, Hamilton JD, Graham NM, Bieber T, Rocklin R, Ming JE, Ren H, Kao R, Simpson E, Ardeleanu M, Weinstein SP, Pirozzi G, Guttman-Yassky E, Suárez-Fariñas M, Hager MD, Stahl N, Yancopoulos GD, Radin AR. Beck LA, et al. N Engl J Med. 2014 Jul 10;371(2):130-9. doi: 10.1056/NEJMoa1314768. N Engl J Med. 2014. PMID: 25006719 Free article. Clinical Trial.
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel.
NIAID-Sponsored Expert Panel; Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA Jr, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM. NIAID-Sponsored Expert Panel, et al. Among authors: beck la. J Allergy Clin Immunol. 2010 Dec;126(6 Suppl):S1-58. doi: 10.1016/j.jaci.2010.10.007. J Allergy Clin Immunol. 2010. PMID: 21134576 Free PMC article.
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.
Thaçi D, Simpson EL, Beck LA, Bieber T, Blauvelt A, Papp K, Soong W, Worm M, Szepietowski JC, Sofen H, Kawashima M, Wu R, Weinstein SP, Graham NM, Pirozzi G, Teper A, Sutherland ER, Mastey V, Stahl N, Yancopoulos GD, Ardeleanu M. Thaçi D, et al. Among authors: beck la. Lancet. 2016 Jan 2;387(10013):40-52. doi: 10.1016/S0140-6736(15)00388-8. Epub 2015 Oct 8. Lancet. 2016. PMID: 26454361 Clinical Trial.
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.
Simpson EL, Lacour JP, Spelman L, Galimberti R, Eichenfield LF, Bissonnette R, King BA, Thyssen JP, Silverberg JI, Bieber T, Kabashima K, Tsunemi Y, Costanzo A, Guttman-Yassky E, Beck LA, Janes JM, DeLozier AM, Gamalo M, Brinker DR, Cardillo T, Nunes FP, Paller AS, Wollenberg A, Reich K. Simpson EL, et al. Among authors: beck la. Br J Dermatol. 2020 Aug;183(2):242-255. doi: 10.1111/bjd.18898. Epub 2020 Mar 5. Br J Dermatol. 2020. PMID: 31995838
1,594 results